Small Biotechs; Big Decisions https://www.citeline.com/biotech⁠ en All rights reserved A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation. View the video series and find out more information here: www.citeline.com/biotech https://megaphone.imgix.net/podcasts/fac729fe-738b-11f1-84e2-77bceffbc60a/image/77edb4f55d99a4501620f284958aa331.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Small Biotechs; Big Decisions https://www.citeline.com/biotech⁠ no serial Norstella A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation. View the video series and find out more information here: www.citeline.com/biotech A limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation.

View the video series and find out more information here: www.citeline.com/biotech

]]> Norstella webpubs@citeline.com The State of Play in Biotech and the Decisions Shaping the Industry Biotech leaders are navigating disciplined growth, shifting global dynamics, and rising expectations across boards, partners, and clinical teams. In this opening episode, a panel of experienced biotech executives step back to discuss where the industry truly stands, the forces shaping decision‑making, and how leaders are approaching strategy, execution, and collaboration in today’s biotech landscape. Featuring: - Claire Riches, VP, Clinical Solutions, Citeline - Ross Pettit, Chief Development Officer, Kestrel Therapeutics - Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus - Marrissa Volpe, SVP, Clinical Development, NervGen - Jennifer Burg, SVP, Clinical Development Operations, Axonis Therapeutics View the video series and find out more information here: https://www.citeline.com/biotech Wed, 12 Aug 2026 15:40:00 -0000 full Norstella Biotech leaders are navigating disciplined growth, shifting global dynamics, and rising expectations across boards, partners, and clinical teams. In this opening episode, a panel of experienced biotech executives step back to discuss where the industry truly stands, the forces shaping decision‑making, and how leaders are approaching strategy, execution, and collaboration in today’s biotech landscape. Featuring: - Claire Riches, VP, Clinical Solutions, Citeline - Ross Pettit, Chief Development Officer, Kestrel Therapeutics - Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus - Marrissa Volpe, SVP, Clinical Development, NervGen - Jennifer Burg, SVP, Clinical Development Operations, Axonis Therapeutics View the video series and find out more information here: https://www.citeline.com/biotech Biotech leaders are navigating disciplined growth, shifting global dynamics, and rising expectations across boards, partners, and clinical teams. In this opening episode, a panel of experienced biotech executives step back to discuss where the industry truly stands, the forces shaping decision‑making, and how leaders are approaching strategy, execution, and collaboration in today’s biotech landscape.


Featuring:

- Claire Riches, VP, Clinical Solutions, Citeline

- Ross Pettit, Chief Development Officer, Kestrel Therapeutics

- Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus

- Marrissa Volpe, SVP, Clinical Development, NervGen

- Jennifer Burg, SVP, Clinical Development Operations, Axonis Therapeutics


View the video series and find out more information here: https://www.citeline.com/biotech

]]> 3658 no Elevate Clinical Operations into a Board Level Strategic Advantage Clinical operations plays a decisive role in execution quality, data integrity, cost control, and development speed, yet it is often treated as a cost centre rather than a strategic function. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Executive Consultant, Clinical Development Operations to discuss why clinical operations must be elevated into board‑level conversations. Together, they explore how clinops drives value, manages risk, and shapes long‑term development strategy, and what boards and executives need to understand to make better, more informed decisions. View the video series and find out more information here: https://www.citeline.com/biotech Fri, 26 Jun 2026 14:20:00 -0000 full Norstella Clinical operations plays a decisive role in execution quality, data integrity, cost control, and development speed, yet it is often treated as a cost centre rather than a strategic function. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Executive Consultant, Clinical Development Operations to discuss why clinical operations must be elevated into board‑level conversations. Together, they explore how clinops drives value, manages risk, and shapes long‑term development strategy, and what boards and executives need to understand to make better, more informed decisions. View the video series and find out more information here: https://www.citeline.com/biotech Clinical operations plays a decisive role in execution quality, data integrity, cost control, and development speed, yet it is often treated as a cost centre rather than a strategic function. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Executive Consultant, Clinical Development Operations to discuss why clinical operations must be elevated into board‑level conversations. Together, they explore how clinops drives value, manages risk, and shapes long‑term development strategy, and what boards and executives need to understand to make better, more informed decisions.


View the video series and find out more information here: https://www.citeline.com/biotech

]]> 3455 no Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design "Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve execution, control costs, and reduce operational risk, while avoiding unnecessary burden on sites and participants. View the video series and find out more information here: https://www.citeline.com/biotech" Mon, 25 May 2026 05:31:00 -0000 full Norstella "Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve execution, control costs, and reduce operational risk, while avoiding unnecessary burden on sites and participants. View the video series and find out more information here: https://www.citeline.com/biotech" "Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve execution, control costs, and reduce operational risk, while avoiding unnecessary burden on sites and participants.


View the video series and find out more information here: https://www.citeline.com/biotech"

]]> 3145 no Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise As biotech models evolve, boards, clinical leaders, and investors are being forced to rethink how value is created. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Ross Pettit, Chief Development Officer, Kestrel Therapeutics, to explore how leaner operating models, sharper board governance, ROI‑driven clinical decisions, and the rapid rise of China’s biotech ecosystem are redefining what “modern biotech” looks like today. #biotech #drugdevelopment #clinicaltrials #clinicaldevelopment #biotechstrategy #biotechleadership #clinicaloperations #ROI #ChinaBiotech  View the video series and find out more information here: https://www.citeline.com/biotech Thu, 23 Apr 2026 10:02:00 -0000 full 7 Norstella As biotech models evolve, boards, clinical leaders, and investors are being forced to rethink how value is created. As biotech models evolve, boards, clinical leaders, and investors are being forced to rethink how value is created. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Ross Pettit, Chief Development Officer, Kestrel Therapeutics, to explore how leaner operating models, sharper board governance, ROI‑driven clinical decisions, and the rapid rise of China’s biotech ecosystem are redefining what “modern biotech” looks like today. #biotech #drugdevelopment #clinicaltrials #clinicaldevelopment #biotechstrategy #biotechleadership #clinicaloperations #ROI #ChinaBiotech  View the video series and find out more information here: https://www.citeline.com/biotech As biotech models evolve, boards, clinical leaders, and investors are being forced to rethink how value is created. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Ross Pettit, Chief Development Officer, Kestrel Therapeutics, to explore how leaner operating models, sharper board governance, ROI‑driven clinical decisions, and the rapid rise of China’s biotech ecosystem are redefining what “modern biotech” looks like today.

#biotech #drugdevelopment #clinicaltrials #clinicaldevelopment #biotechstrategy #biotechleadership #clinicaloperations #ROI #ChinaBiotech  View the video series and find out more information here: https://www.citeline.com/biotech

]]> 0 no Winning Biotech Investors Through Strategic Partnerships and Trial Innovation https://soundcloud.com/citelinesounds/winning-biotech-investors-through-strategic-partnerships-and-trial-innovation Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success. View the video series and find out more information here: https://www.citeline.com/biotech Wed, 22 Oct 2025 10:07:00 -0000 full Norstella Biotech funding is tougher than ever, but some co… Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CEO of Worldwide Clinical Trials as they reveal insider strategies for securing investors, navigating partnerships, and turning innovative science into real-world success. View the video series and find out more information here: https://www.citeline.com/biotech 2759 no Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech https://soundcloud.com/citelinesounds/drive-early-cro-engagement-to-optimize-funding-trial-design-and-recruitment-in-biotech What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy, IQVIA Biotech, share the secrets behind winning biotech-CRO partnerships, covering collaboration, transparent budgeting, regulatory navigation, and recruitment strategies, with essential insights to help biotechs succeed from their first RFP to global trials. View the video series and find out more information here: https://www.citeline.com/biotech Fri, 12 Sep 2025 09:45:00 -0000 full Norstella What makes a biotech-CRO partnership truly work? … What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy, IQVIA Biotech, share the secrets behind winning biotech-CRO partnerships, covering collaboration, transparent budgeting, regulatory navigation, and recruitment strategies, with essential insights to help biotechs succeed from their first RFP to global trials. View the video series and find out more information here: https://www.citeline.com/biotech 3169 no Master Regulatory Hurdles and Accelerate Your Drug Development https://soundcloud.com/citelinesounds/weathering-the-storm-love-laws-and-global-trials-fda-regulations-biotech-in-2025 With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech Mon, 30 Jun 2025 08:33:00 -0000 full Norstella With growing FDA bottlenecks and regulatory chang… With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing real-world data, and finding new global pathways to bring therapies to life. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech 823 no How to Crush Competitive Threats and Stand Out in Biotech https://soundcloud.com/citelinesounds/50ec21d4-b0de-4865-9682-a37ae7cd8c53 The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsmart rivals and change the game. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech Mon, 23 Jun 2025 13:05:00 -0000 full Norstella The race for new therapies is more intense than e… The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsmart rivals and change the game. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech 858 no Strategies to Secure Critical Biotech Funding Amid Market Challenges https://soundcloud.com/citelinesounds/through-thick-and-thin-funding-the-future-with-grit Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug development. Is reinvention biotech’s last hope? Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech Wed, 11 Jun 2025 16:24:00 -0000 full Norstella Biotechs are racing to change the rules in this t… Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping drug development. Is reinvention biotech’s last hope? Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech 902 no How to Survive Innovation Pressure in Today’s Biotech Landscape https://soundcloud.com/citelinesounds/first-sparks-falling-for-innovation-in-a-harsh-market Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. This episode explores how biotechs ignite innovation despite economic headwinds, regulatory uncertainty, and fierce competition. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech Wed, 11 Jun 2025 16:14:00 -0000 full Norstella Small biotech companies are facing tough times, s… Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resilience are rising. This episode explores how biotechs ignite innovation despite economic headwinds, regulatory uncertainty, and fierce competition. Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella, and Claire Riches, VP of Clinical Solutions at Citeline, a leading provider of life sciences data and insights. View the video series and find out more information here: https://www.citeline.com/biotech 581 no